QALY weightings based on burden of illness applied to a UK cost-effectiveness analysis of nab-paclitaxel + gemcitabine for the treatment of metastatic pancreatic cancer

Authors:

Cowell W, Henry T, Gladwell D, Parnaby A.

Publication Type:

Conference Proceedings – Poster

Publication Name:

17th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Cowell W, Henry T, Gladwell D and Parnaby A. QALY weightings based on burden of illness applied to a UK cost-effectiveness analysis of nab-paclitaxel + gemcitabine for the treatment of metastatic pancreatic cancer. 17th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Amsterdam, The Netherlands. 8–12 November 2014. Poster PCN158.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies